Human-run account.
This article explains the reality well.
In many other countries, additional work is not income survival, but portfolio careers built into the system.
oncall.fastdoctor.jp/media/column...
This article explains the reality well.
In many other countries, additional work is not income survival, but portfolio careers built into the system.
oncall.fastdoctor.jp/media/column...
This article clearly explains how the loss of regional medical institutions leads to job loss, depopulation, and community decline.
www.ringe.jp/civic/medica...
This article clearly explains how the loss of regional medical institutions leads to job loss, depopulation, and community decline.
www.ringe.jp/civic/medica...
They are infrastructure.
When hospitals are closed to fix short-term deficits,
jobs disappear, people leave,
and entire communities hollow out.
This is not cost containment.
It is long-term national loss.
#HealthSystems
They are infrastructure.
When hospitals are closed to fix short-term deficits,
jobs disappear, people leave,
and entire communities hollow out.
This is not cost containment.
It is long-term national loss.
#HealthSystems
clinical work and academic work
follow different compensation models.
In Japan, they often do not.
That difference quietly shapes
who stays in academic medicine.
#AcademicMedicine
clinical work and academic work
follow different compensation models.
In Japan, they often do not.
That difference quietly shapes
who stays in academic medicine.
#AcademicMedicine
over improper travel reimbursement — about $70.
The misconduct was real and unacceptable.
But the case highlights a deeper issue:
world-class physicians working under
low pay, rigid rules, and zero tolerance for error.
#HealthSystems
over improper travel reimbursement — about $70.
The misconduct was real and unacceptable.
But the case highlights a deeper issue:
world-class physicians working under
low pay, rigid rules, and zero tolerance for error.
#HealthSystems
It protects patients from catastrophic costs
and enables broad access to standard care.
But as adjuvant therapies reach
$600k–$900k over five years,
the question quietly shifts:
not whether patients can pay,
but whether the system can absorb it.
#BreastCancer
It protects patients from catastrophic costs
and enables broad access to standard care.
But as adjuvant therapies reach
$600k–$900k over five years,
the question quietly shifts:
not whether patients can pay,
but whether the system can absorb it.
#BreastCancer
may cost $600k–$900k over five years.
That shifts the question from efficacy
to whether health systems can actually deliver it.
#BreastCancer #SABCS #SERD
may cost $600k–$900k over five years.
That shifts the question from efficacy
to whether health systems can actually deliver it.
#BreastCancer #SABCS #SERD
Across ASCO, ESMO, and SABCS, one assumption stood out:
access, timelines, and infrastructure are already in place.
For many clinicians, they are not.
That gap now matters as much as the evidence itself.
#Oncology
Across ASCO, ESMO, and SABCS, one assumption stood out:
access, timelines, and infrastructure are already in place.
For many clinicians, they are not.
That gap now matters as much as the evidence itself.
#Oncology
consistency becomes fragile.
Is that really a sustainable system?
consistency becomes fragile.
Is that really a sustainable system?
Clinical practice rarely has them.
Most variation in care quality starts there.
Clinical practice rarely has them.
Most variation in care quality starts there.
It’s about noticing the gaps between clinical reality and system design —
and how those gaps quietly shape the quality of care.
It’s about noticing the gaps between clinical reality and system design —
and how those gaps quietly shape the quality of care.